Company Filing History:
Years Active: 2015-2018
Title: The Innovative Journey of Anna-Carin Wallgren
Introduction
Anna-Carin Wallgren, an accomplished inventor based in Uppsala, Sweden, has made significant contributions to the field of immunology. With a focus on developing innovative methods for T cell priming and proliferation, her research is paving the way for new treatments for viral infections and tumors. With a total of five patents to her name, Wallgren's work exemplifies the intersection of science and practical application.
Latest Patents
Among her latest patents, Wallgren has developed a groundbreaking method for priming T cells. This invention pertains to an in vitro method designed for T cell priming, specifically suitable for patients suffering from viral infections. The patent also includes the composition obtained from this method and its subsequent applications. Another notable patent details a method for proliferating antigen-specific T cells. This invention focuses on an in vitro method for priming genetically modified T cells aimed at treating patients with tumors, along with the composition produced by this method and its various uses.
Career Highlights
Wallgren's career at Immunicum AB has been marked by her dedication to advancing immunotherapy techniques. Her expertise and innovative spirit have played a pivotal role in the development of cutting-edge treatments. As she continues to push the boundaries of medical science, her work stands as a testament to the potential of immunological innovations.
Collaborations
In her endeavors, Wallgren has collaborated with esteemed colleagues, including Alex Karlsson-Parra and Bengt Andersson. These partnerships are crucial in fostering an environment of innovation, where multidisciplinary approaches can thrive and lead to breakthrough advancements in treatment methodologies.
Conclusion
Anna-Carin Wallgren exemplifies the spirit of innovation in the field of immunology. Her patents not only represent her ingenuity but also highlight her commitment to developing solutions for pressing medical challenges. With continued collaboration and research, Wallgren is set to impact the future of medical treatments significantly, providing hope for patients in need.